SAN DIEGO and GENEVA, Jan. 12, 2026 /PRNewswire/ — The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to n-Lorem’s antisense oligonucleotide (ASO) therapies for patients with rare genetic diseases. The collaboration…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
